CLINICAL_TRIALS
trial_result
· 2023-03-30
Clinical Trial Update: A Study to Test the Effectiveness and Safety of Fremanezumab on Participants With Fibromyalgia [Phase 2]
Summary
Phase 2 trial assessing fremanezumab for fibromyalgia was terminated; results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Teva Branded Pharmaceutical Products R&D, Inc. | Conditions: Fibromyalgia | Phase 2 | Status: TERMINATED | Results posted: 2023-03-30